An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers

Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent rea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human brain mapping 2018-01, Vol.39 (1), p.319-331
Hauptverfasser: Hawkins, Peter C.T., Wood, Tobias C., Vernon, Anthony C., Bertolino, Alessandro, Sambataro, Fabio, Dukart, Juergen, Merlo‐Pich, Emilio, Risterucci, Celine, Silber‐Baumann, Hanna, Walsh, Eamonn, Mazibuko, Ndabezinhle, Zelaya, Fernando O., Mehta, Mitul A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 331
container_issue 1
container_start_page 319
container_title Human brain mapping
container_volume 39
creator Hawkins, Peter C.T.
Wood, Tobias C.
Vernon, Anthony C.
Bertolino, Alessandro
Sambataro, Fabio
Dukart, Juergen
Merlo‐Pich, Emilio
Risterucci, Celine
Silber‐Baumann, Hanna
Walsh, Eamonn
Mazibuko, Ndabezinhle
Zelaya, Fernando O.
Mehta, Mitul A.
description Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.
doi_str_mv 10.1002/hbm.23844
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6866296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1972998340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EoqWw4AWQJVYs0vovTrxBaiugSEVsYG05zs3ElWMPtjPVPAjvi8uUESxY-Uj-dM699yD0mpJzSgi7mIflnPFeiCfolBLVNYQq_vRBy7ZRoqMn6EXOd4RQ2hL6HJ0wRdqet_0p-nkZsAs7yMVtTHEx4DjhBJuqjMcWEgypisHHOOLJx3tswoiLy3kFnEtabVkTYDubsIGMzVQgYWPXAtiMiwuuMkdfE4rb5r2dY3E211w8g_Fl3uPFeMC76NdQAFJ-iZ5Nxmd49fieoe8fP3y7vmluv376fH1521ghuGh6O0nLlW0Zo5RLIsZukKTnjEkxSmFgFD2rF5oGVbdtDWeEE0EIdMoMkhp-ht4ffLfrsMBoIdRpvd4mt5i019E4_e9PcLPexJ2WvZRMyWrw9tEgxR9rvaK-i2uqp8uaqo6pmitIpd4dKJtizgmmYwIl-qFBXRvUvxus7Ju_RzqSfyqrwMUBuHce9v930jdXXw6WvwDFWqjm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1972998340</pqid></control><display><type>article</type><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><source>MEDLINE</source><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</creator><creatorcontrib>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</creatorcontrib><description>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</description><identifier>ISSN: 1065-9471</identifier><identifier>EISSN: 1097-0193</identifier><identifier>DOI: 10.1002/hbm.23844</identifier><identifier>PMID: 29058358</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>acute ; Acute effects ; Adult ; Antipsychotic Agents - blood ; Antipsychotic Agents - pharmacology ; Antipsychotics ; Artefacts ; Benzodiazepines - blood ; Benzodiazepines - pharmacology ; Blood flow ; Blood pressure ; Brain ; Brain - diagnostic imaging ; Brain - drug effects ; Brain - physiology ; Brain Mapping ; CBF ; Cerebral blood flow ; Cerebrovascular Circulation - drug effects ; Cerebrovascular Circulation - physiology ; Clinical trials ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug dosages ; Drugs ; Haloperidol ; Haloperidol - blood ; Haloperidol - pharmacology ; Humans ; Image acquisition ; Magnetic Resonance Imaging ; Male ; Males ; Mental disorders ; Neostriatum ; Neuroimaging ; Olanzapine ; Psychotropic drugs ; relaxometry ; Risperidone ; Risperidone - blood ; Risperidone - pharmacology ; Schizophrenia ; structural MRI ; Young Adult</subject><ispartof>Human brain mapping, 2018-01, Vol.39 (1), p.319-331</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</citedby><cites>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</cites><orcidid>0000-0002-2256-1648</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866296/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866296/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,27924,27925,45574,45575,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29058358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hawkins, Peter C.T.</creatorcontrib><creatorcontrib>Wood, Tobias C.</creatorcontrib><creatorcontrib>Vernon, Anthony C.</creatorcontrib><creatorcontrib>Bertolino, Alessandro</creatorcontrib><creatorcontrib>Sambataro, Fabio</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Merlo‐Pich, Emilio</creatorcontrib><creatorcontrib>Risterucci, Celine</creatorcontrib><creatorcontrib>Silber‐Baumann, Hanna</creatorcontrib><creatorcontrib>Walsh, Eamonn</creatorcontrib><creatorcontrib>Mazibuko, Ndabezinhle</creatorcontrib><creatorcontrib>Zelaya, Fernando O.</creatorcontrib><creatorcontrib>Mehta, Mitul A.</creatorcontrib><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><title>Human brain mapping</title><addtitle>Hum Brain Mapp</addtitle><description>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</description><subject>acute</subject><subject>Acute effects</subject><subject>Adult</subject><subject>Antipsychotic Agents - blood</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotics</subject><subject>Artefacts</subject><subject>Benzodiazepines - blood</subject><subject>Benzodiazepines - pharmacology</subject><subject>Blood flow</subject><subject>Blood pressure</subject><subject>Brain</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - drug effects</subject><subject>Brain - physiology</subject><subject>Brain Mapping</subject><subject>CBF</subject><subject>Cerebral blood flow</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Cerebrovascular Circulation - physiology</subject><subject>Clinical trials</subject><subject>Cross-Over Studies</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Drug dosages</subject><subject>Drugs</subject><subject>Haloperidol</subject><subject>Haloperidol - blood</subject><subject>Haloperidol - pharmacology</subject><subject>Humans</subject><subject>Image acquisition</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Males</subject><subject>Mental disorders</subject><subject>Neostriatum</subject><subject>Neuroimaging</subject><subject>Olanzapine</subject><subject>Psychotropic drugs</subject><subject>relaxometry</subject><subject>Risperidone</subject><subject>Risperidone - blood</subject><subject>Risperidone - pharmacology</subject><subject>Schizophrenia</subject><subject>structural MRI</subject><subject>Young Adult</subject><issn>1065-9471</issn><issn>1097-0193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EoqWw4AWQJVYs0vovTrxBaiugSEVsYG05zs3ElWMPtjPVPAjvi8uUESxY-Uj-dM699yD0mpJzSgi7mIflnPFeiCfolBLVNYQq_vRBy7ZRoqMn6EXOd4RQ2hL6HJ0wRdqet_0p-nkZsAs7yMVtTHEx4DjhBJuqjMcWEgypisHHOOLJx3tswoiLy3kFnEtabVkTYDubsIGMzVQgYWPXAtiMiwuuMkdfE4rb5r2dY3E211w8g_Fl3uPFeMC76NdQAFJ-iZ5Nxmd49fieoe8fP3y7vmluv376fH1521ghuGh6O0nLlW0Zo5RLIsZukKTnjEkxSmFgFD2rF5oGVbdtDWeEE0EIdMoMkhp-ht4ffLfrsMBoIdRpvd4mt5i019E4_e9PcLPexJ2WvZRMyWrw9tEgxR9rvaK-i2uqp8uaqo6pmitIpd4dKJtizgmmYwIl-qFBXRvUvxus7Ju_RzqSfyqrwMUBuHce9v930jdXXw6WvwDFWqjm</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Hawkins, Peter C.T.</creator><creator>Wood, Tobias C.</creator><creator>Vernon, Anthony C.</creator><creator>Bertolino, Alessandro</creator><creator>Sambataro, Fabio</creator><creator>Dukart, Juergen</creator><creator>Merlo‐Pich, Emilio</creator><creator>Risterucci, Celine</creator><creator>Silber‐Baumann, Hanna</creator><creator>Walsh, Eamonn</creator><creator>Mazibuko, Ndabezinhle</creator><creator>Zelaya, Fernando O.</creator><creator>Mehta, Mitul A.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2256-1648</orcidid></search><sort><creationdate>201801</creationdate><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><author>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>acute</topic><topic>Acute effects</topic><topic>Adult</topic><topic>Antipsychotic Agents - blood</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotics</topic><topic>Artefacts</topic><topic>Benzodiazepines - blood</topic><topic>Benzodiazepines - pharmacology</topic><topic>Blood flow</topic><topic>Blood pressure</topic><topic>Brain</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - drug effects</topic><topic>Brain - physiology</topic><topic>Brain Mapping</topic><topic>CBF</topic><topic>Cerebral blood flow</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Cerebrovascular Circulation - physiology</topic><topic>Clinical trials</topic><topic>Cross-Over Studies</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Drug dosages</topic><topic>Drugs</topic><topic>Haloperidol</topic><topic>Haloperidol - blood</topic><topic>Haloperidol - pharmacology</topic><topic>Humans</topic><topic>Image acquisition</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Males</topic><topic>Mental disorders</topic><topic>Neostriatum</topic><topic>Neuroimaging</topic><topic>Olanzapine</topic><topic>Psychotropic drugs</topic><topic>relaxometry</topic><topic>Risperidone</topic><topic>Risperidone - blood</topic><topic>Risperidone - pharmacology</topic><topic>Schizophrenia</topic><topic>structural MRI</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawkins, Peter C.T.</creatorcontrib><creatorcontrib>Wood, Tobias C.</creatorcontrib><creatorcontrib>Vernon, Anthony C.</creatorcontrib><creatorcontrib>Bertolino, Alessandro</creatorcontrib><creatorcontrib>Sambataro, Fabio</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Merlo‐Pich, Emilio</creatorcontrib><creatorcontrib>Risterucci, Celine</creatorcontrib><creatorcontrib>Silber‐Baumann, Hanna</creatorcontrib><creatorcontrib>Walsh, Eamonn</creatorcontrib><creatorcontrib>Mazibuko, Ndabezinhle</creatorcontrib><creatorcontrib>Zelaya, Fernando O.</creatorcontrib><creatorcontrib>Mehta, Mitul A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human brain mapping</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawkins, Peter C.T.</au><au>Wood, Tobias C.</au><au>Vernon, Anthony C.</au><au>Bertolino, Alessandro</au><au>Sambataro, Fabio</au><au>Dukart, Juergen</au><au>Merlo‐Pich, Emilio</au><au>Risterucci, Celine</au><au>Silber‐Baumann, Hanna</au><au>Walsh, Eamonn</au><au>Mazibuko, Ndabezinhle</au><au>Zelaya, Fernando O.</au><au>Mehta, Mitul A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</atitle><jtitle>Human brain mapping</jtitle><addtitle>Hum Brain Mapp</addtitle><date>2018-01</date><risdate>2018</risdate><volume>39</volume><issue>1</issue><spage>319</spage><epage>331</epage><pages>319-331</pages><issn>1065-9471</issn><eissn>1097-0193</eissn><abstract>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>29058358</pmid><doi>10.1002/hbm.23844</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-2256-1648</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1065-9471
ispartof Human brain mapping, 2018-01, Vol.39 (1), p.319-331
issn 1065-9471
1097-0193
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6866296
source MEDLINE; Wiley Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects acute
Acute effects
Adult
Antipsychotic Agents - blood
Antipsychotic Agents - pharmacology
Antipsychotics
Artefacts
Benzodiazepines - blood
Benzodiazepines - pharmacology
Blood flow
Blood pressure
Brain
Brain - diagnostic imaging
Brain - drug effects
Brain - physiology
Brain Mapping
CBF
Cerebral blood flow
Cerebrovascular Circulation - drug effects
Cerebrovascular Circulation - physiology
Clinical trials
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Drug dosages
Drugs
Haloperidol
Haloperidol - blood
Haloperidol - pharmacology
Humans
Image acquisition
Magnetic Resonance Imaging
Male
Males
Mental disorders
Neostriatum
Neuroimaging
Olanzapine
Psychotropic drugs
relaxometry
Risperidone
Risperidone - blood
Risperidone - pharmacology
Schizophrenia
structural MRI
Young Adult
title An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A54%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20investigation%20of%20regional%20cerebral%20blood%20flow%20and%20tissue%20structure%20changes%20after%20acute%20administration%20of%20antipsychotics%20in%20healthy%20male%20volunteers&rft.jtitle=Human%20brain%20mapping&rft.au=Hawkins,%20Peter%20C.T.&rft.date=2018-01&rft.volume=39&rft.issue=1&rft.spage=319&rft.epage=331&rft.pages=319-331&rft.issn=1065-9471&rft.eissn=1097-0193&rft_id=info:doi/10.1002/hbm.23844&rft_dat=%3Cproquest_pubme%3E1972998340%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1972998340&rft_id=info:pmid/29058358&rfr_iscdi=true